The moon will pass in front of Regulus for some observers on May 23, blocking its light.

Skywatchers in parts of the Pacific will witness the moon block Regulus, while others worldwide can observe the celestial duo ...

Novartis has announced that it will be acquiring Regulus Therapeutics in a deal worth $1.7bn, marking a notable boost to the drugmaker’s renal disease pipeline. The agreement will give Novartis access ...

According to NASA, this parallax effect can cause the moon's apparent position in the sky to vary by as much as 2 degrees ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Add Yahoo as a preferred source to see more of our stories on Google. July 10, 2023 at 8:50 pm - Mars Meets Regulus, near Venus, in the sky The night sky makes for an interesting pairing of targets ...

The article details the celestial configuration of the waning Moon and Regulus in the constellation Leo for observation on October 15. Regulus is identified as a magnitude 1.4, quadruple-star system, ...

Does Regulus Therapeutics Have A Long Cash Runway? A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. As at December 2024, ...

Regulus Therapeutics Inc. (NASDAQ:RGLS) released topline results from all patients in the fourth cohort in its Phase 1b MAD study of farabursen (RGLS8429) autosomal dominant polycystic kidney disease ...

Novartis AG has agreed to buy U.S. biotech firm Regulus Therapeutics Inc. in a deal that could be valued at up to $1.7 billion. The Swiss company will pay $7 a share in cash up-front through a ...